Clinical Chemistry · 2015 · 41 citations · 22 references
Life SciencesMolecular BiologyBiosensorsImmunotechnologyMolecular DiagnosticsBiomarker DevelopmentBiomarker DiscoveryDementia BiomarkersEnzyme-linked Immunosorbent AssayMicrorna BiologyMolecular BiomarkersAnalytical SensitivityAnalytical SpecificityAssayAssay ReproducibilityBiomarkersImmunoassay MethodologyMicrorna BiomarkersMicrorna Profiling
BACKGROUND: The implementation of new biomarkers into clinical practice is one of the most important areas in medical research. Besides their clinical impact, novel in vitro diagnostic markers promise to have a substantial effect on healthcare costs. Although numerous publications report the discovery of biomarkers, only a fraction of those markers are routinely used. One key challenge is a measurement system that is compatible with clinical workflows. METHODS: We designed a new immunoassay for microRNA (miRNA) quantification. The assay combines streptavidin-linked microparticles, a biotinylated catcher oligonucleotide complementary to a single miRNA species, and finally, a monoclonal antibody to DNA/RNA heterohybrids labeled with acridinium ester. Importantly, our assay runs on standard immunoassay analyzers. After a technical validation of the assay, we evaluated the clinical performance on 4 Alzheimer disease miRNAs. RESULTS: Our assay has an analytical specificity of 99.4% and is at the same time sensitive (concentrations in the range of 1 pmol/L miRNA can be reliably profiled). Because the novel approach did not require amplification steps, we obtained high reproducibility for up to 40 biological replicates. Importantly, our assay prototype exhibited a time to result of <3 h. With human blood samples, the assay was able to measure 4 miRNAs that can detect Alzheimer disease with a diagnostic accuracy of 82% and showed a Pearson correlation >0.994 with the gold standard qRT-PCR. CONCLUSIONS: Our miRNA immunoassay allowed the measurement of miRNA signatures with sufficient analytical sensitivity and high specificity on commonly available laboratory equipment.
22
Most mammalian mRNAs are conserved targets of microRNAs
Robin C. Friedman, Kyle Kai‐How Farh, Christopher B. Burge et al. · Genome Research · 2008 · 8.6K citations · Full text
Real-time quantification of microRNAs by stem-loop RT-PCR
C. Chen · Nucleic Acids Research · 2005 · 5K citations · Full text
An Analysis of Human MicroRNA and Disease Associations
Ming Lü, Qipeng Zhang, Min Deng et al. · PLoS ONE · 2008 · 913 citations · Full text
A blood based 12-miRNA signature of Alzheimer disease patients
Petra Leidinger, Christina Backes, Stephanie Deutscher et al. · Genome biology · 2013 · 512 citations · Full text